BARD ASSOCIATES INC - OCULUS INNOVATIVE SCIENCES I ownership

OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 17 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARD ASSOCIATES INC ownership history of OCULUS INNOVATIVE SCIENCES I
ValueSharesWeighting
Q1 2016$553,000
-17.2%
579,126
-0.3%
0.32%
-19.0%
Q4 2015$668,000
+1032.2%
581,126
+2929.2%
0.39%
+1613.0%
Q2 2014$59,000
-92.0%
19,184
-90.2%
0.02%
-92.7%
Q1 2014$742,000
+4.8%
196,685
-3.6%
0.31%
+6.4%
Q4 2013$708,000
+13.6%
204,111
-10.3%
0.30%
+6.9%
Q3 2013$623,000
+258.0%
227,461
+236.4%
0.28%
+240.7%
Q2 2013$174,00067,6110.08%
Other shareholders
OCULUS INNOVATIVE SCIENCES I shareholders Q3 2014
NameSharesValueWeighting ↓
B. Riley Wealth Advisors, Inc. 109,303$142,0000.03%
NWAM LLC 24,000$31,0000.03%
WADE G W & INC 45,000$58,0000.01%
UBS Group AG 185$00.00%
NOMURA HOLDINGS INC 23,800$31,0000.00%
BANK OF AMERICA CORP /DE/ 6,200$8,0000.00%
WELLS FARGO & COMPANY/MN 6,371$9,0000.00%
NORTHERN TRUST CORP 19,526$26,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 67,116$86,0000.00%
CITIGROUP INC 171$00.00%
View complete list of OCULUS INNOVATIVE SCIENCES I shareholders